Newswire (Published: Monday, December 18, 2017, Received: Thursday, December 14, 2017, 12:45:06 PM CST)

Word Count: 388

Researchers from University of Chicago Provide Details of New Studies and Findings in the Area of Prostatectomy (Managing Cancer Relapse After Radical Prostatectomy Adjuvant Versus Salvage Radiation Therapy)

By a News Reporter-Staff News Editor at Clinical Trials Week -- Fresh data on Surgery - Prostatectomy are presented in a new report. According to news reporting from Chicago, Illinois, by NewsRx journalists, research stated, "An increasing proportion of men are undergoing radical prostatectomy for locally advanced prostate cancer. More than half of men with adverse pathologic features are expected to experience disease recurrence within 10 years."

The news correspondents obtained a quote from the research from the University of Chicago, "This article discusses the use of postoperative radiation therapy to decrease this risk. Evidence from 3 randomized trials and multiple retrospective studies indicates that either adjuvant or salvage radiation improves biochemical progression-free survival and may improve overall survival."

According to the news reporters, the research concluded: "Novel imaging and genomic analysis can improve patient selection for either modality; however, current tests are unable to identify all patients who may benefit from additional local therapy."

For more information on this research see: Managing Cancer Relapse After Radical Prostatectomy Adjuvant Versus Salvage Radiation Therapy. Urologic Clinics of North America, 2017;44(4):597-609,CP3. Urologic Clinics of North America can be contacted at: W B Saunders Co-Elsevier Inc, 1600 John F Kennedy Boulevard, Ste 1800, Philadelphia, PA 19103-2899, USA. (Elsevier - www.elsevier.com; Urologic Clinics of North America - www.journals.elsevier.com/urologic-clinics-of-north-america/)

Our news journalists report that additional information may be obtained by contacting J.F. Rodriguez, University Chicago, Univ Chicago Med, Sect Urol, Chicago, IL 60637, United States. Additional authors for this research include S.L. Liauw and S.E. Eggener (see also Surgery - Prostatectomy).

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.ucl.2017.07.011. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Keywords for this news article include: Chicago, Illinois, United States, North and Central America, Health and Medicine, Drugs and Therapies, Radiation Therapy, Prostatectomy, Oncology, Surgery, Cancer, University of Chicago.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

Companies

The University of Chicago

Industries

Biotechnology
      Biopharmaceuticals
Pharmaceuticals
      Biopharmaceuticals

Places

Central America
North America
United States
Americas
Illinois
Pennsylvania
Chicago
Philadelphia

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
      Medical Specialties and Practices
            Radiology
            Surgery
      Treatments and Therapies
            Medicinal Drugs
            Radiation Therapy
            Surgery